myelofibrosis therapies in clinical trials | bet inhibitors
Published 8 months ago • 24 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:57
advances in myelofibrosis research
-
8:52
which emerging myelofibrosis therapies are showing promise?
-
5:02
considering a myelofibrosis clinical trial? questions you should ask
-
4:34
what are the considerations when choosing myelofibrosis therapy?
-
2:43
how does inhibitor therapy work to treat myelofibrosis?
-
30:42
evolving myelofibrosis treatment options: what you should know
-
2:41
myelofibrosis clinical trial participation | how does it move research forward?
-
2:03
expert perspective: promising myelofibrosis treatment research
-
7:29
what are the currently approved myelofibrosis therapies?
-
2:18
abbv-744 and mivebresib: bet inhibitors in myelofibrosis
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
1:59
what is the rationale for using bet inhibitors to treat myelofibrosis?
-
19:11
novel agents and combination therapies in myelofibrosis
-
4:58
treatment of myelofibrosis: emerging therapies
-
2:08
cpi-0610: a novel bet inhibitor for mf
-
33:24
which mpn treatment is right for you? what you need to know
-
2:55
impactmf: imetelstat vs best available therapy in patients with myelofibrosis
-
4:26
bet inhibition as a novel targeted therapy for myelofibrosis
-
1:34
pelabresib in myelofibrosis: the manifest trials